Skip to main content
PCI Biotech Holding logo

PCI Biotech Holding — Investor Relations & Filings

Ticker · PCIB ISIN · NO0010405640 LEI · 5967007LIEEXZXFIGG77 OL Manufacturing
Open in API
Filings indexed 752 across all filing types
Latest filing 2017-08-29 Report Publication Anno…
Country NO Norway
Listing OL PCIB

About PCI Biotech Holding

https://www.pcibiotech.no/

PCI Biotech Holding is a biopharmaceutical company developing therapeutic products based on its proprietary Photochemical Internalization (PCI) technology. This platform is a drug and nucleic acid delivery system designed to enhance the intracellular delivery of therapeutic molecules. The company's development programs are focused on applications in immunotherapy, dermatology, and bioprocessing for the manufacturing of viral vectors. A primary therapeutic area for the technology is cancer, where it aims to improve the efficacy of novel and existing treatments.

Recent filings

Filing Released Lang Actions
PCI Biotech: First half year 2017 report and presentation
Report Publication Announcement Classification · 95% confidence The document is a short announcement (approx. 6,100 characters) from PCI Biotech regarding the release of their first-half 2017 financial report and presentation. It explicitly states 'Please find enclosed the financial report and presentation' and provides details on how to access them, including a link to a live audiocast. Per the 'Menu vs Meal' rule, because this document serves as an announcement of the report rather than the comprehensive financial report itself, it is classified as a Report Publication Announcement (RPA). H1 2017
2017-08-29 English
PCI Biotech appoints Dr Hans Olivecrona as Chief Medical Officer
Board/Management Information Classification · 99% confidence The document is an announcement titled "PCI Biotech appoints Dr Hans Olivecrona as Chief Medical Officer". It details the hiring of a new senior executive (CMO) and includes quotes from the CEO and the new CMO regarding the appointment and the company's pipeline. This content directly relates to changes in senior management personnel. According to the definitions, this falls under Board/Management Information (MANG). The document length is relatively short (4656 chars), but it is the primary announcement itself, not a notice about another report, so RPA/RNS is less appropriate than the specific content classification.
2017-08-23 English
PCI Biotech: Invitation to first half year 2017 presentation
Report Publication Announcement Classification · 98% confidence The document is an invitation to a presentation covering the company's 'second quarter and first half year 2017 report'. It explicitly states that the 'interim report and the presentation will be available' at a specific time and location. Since the document itself is an invitation/announcement about the release of the actual financial report (Interim Report), and given its short length (1309 chars), it fits the definition of a Report Publication Announcement (RPA). It is not the comprehensive Interim Report (IR) itself, nor is it a Call Transcript (CT) or Earnings Release (ER), but rather the notice preceding the release of those materials.
2017-08-21 English
PCI Biotech: First patient dosed in the fimaCHEM Phase I extension study
Legal Proceedings Report Classification · 99% confidence The document announces a clinical trial update: 'First patient dosed in the fimaCHEM Phase I extension study'. It details the progress of a clinical study, including objectives, patient numbers, and investigator comments. This type of announcement, focusing on clinical trial milestones, is typically classified as a general corporate update or news release rather than a formal financial filing like a 10-K, Earnings Release (ER), or Interim Report (IR). Since it is a specific operational announcement that doesn't fit the other specialized categories (like M&A, Capital Change, or Director Dealing), it falls best under the general Regulatory Filings/Announcements category (RNS), which serves as a broad category for non-standard, material company news releases, especially those related to R&D progress.
2017-08-11 English
Disclosure of shareholding
Major Shareholding Notification Classification · 99% confidence The document explicitly details a transaction involving shares purchased by a director/insider (Kjetil Myrlid Aasen) and the resulting change in their total shareholding percentage (from 4.97% to 5.01%). This directly corresponds to the definition of Director's Dealing (DIRS) or Major Shareholding Notification (MRQ). Since the text focuses on the transaction by an individual associated with management/board and the resulting change in ownership threshold crossing, DIRS is the most precise fit, as it covers personal share transactions by directors/executives. MRQ is typically for notifications of significant share ownership changes by any entity crossing a threshold, but DIRS specifically covers insider transactions.
2017-07-21 English
PCI Biotech: Extension of preclinical research collaboration agreement with a top-10 large pharma company
Regulatory Filings Classification · 95% confidence The document is a press release announcing the extension of a preclinical research collaboration agreement between PCI Biotech and an undisclosed top-10 pharma company. It details the nature of the extension (covering in vivo studies until the end of 2017) and provides company background. This type of announcement, which details strategic business developments, partnerships, or research progress outside of standard mandatory financial reports (like 10-K or IR), typically falls under general regulatory announcements or investor relations news. Since it is not a formal financial report (ER, IR, 10-K), a specific transaction (TAR, SHA, POS), or a management change (MANG), the most appropriate general category for significant, non-financial operational news is Regulatory Filings (RNS), which serves as a broad category for official company announcements not covered elsewhere. The document length is short (3733 chars) and it is a direct announcement, not a report itself.
2017-07-10 English

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.